Evidence map›Paper›PMID 33983565›Full record

ArticleHealth care management science2021

Predicting rapid progression phases in glaucoma using a soft voting ensemble classifier exploiting Kalman filtering.

Isaac A Jones, Mark P Van Oyen, Mariel S Lavieri, Christopher A Andrews, Joshua D Stein

Abstract read
PubMed Publisher
In one paragraph

Article in Health care management science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Isaac A JonesDepartment of Industrial and Operations Engineering, University of Michigan, Ann Arbor, MI, 48109, USA.
Mark P Van OyenDepartment of Industrial and Operations Engineering, University of Michigan, Ann Arbor, MI, 48109, USA. vanoyen@umich.edu.ORCID http://orcid.org/0000-0002-8685-7843
Mariel S LavieriDepartment of Industrial and Operations Engineering, University of Michigan, Ann Arbor, MI, 48109, USA.
Christopher A AndrewsKellogg Eye Institute, Ann Arbor, MI, 48105, USA.
Joshua D SteinKellogg Eye Institute, Ann Arbor, MI, 48105, USA.

Funding

Personalized Forecasting of Disease Trajectory for Patients with Open Angle GlaucomaR01EY026641 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LAVIERI-WILLIAMS, MARIEL SOFIA, STEIN, JOSHUA D · 2016 to 2020
$2.9M
National Science Foundation CMMI-1548201NIH HHS R01EY026641
6 · The paper itself

Abstract

In managing patients with chronic diseases, such as open angle glaucoma (OAG), the case treated in this paper, medical tests capture the disease phase (e.g. regression, stability, progression, etc.) the patient is currently in. When medical tests have low residual variability (e.g. empirical difference between the patient's true and recorded value is small) they can effectively, without the use of sophisticated methods, identify the patient's current disease phase; however, when medical tests have moderate to high residual variability this may not be the case. This paper presents a framework for handling the latter case. The framework presented integrates the outputs of interacting multiple model Kalman filtering with supervised learning classification. The purpose of this integration is to estimate the true values of patients' disease metrics by allowing for rapid and non-rapid phases; and dynamically adapting to changes in these values over time. We apply our framework to classifying whether a patient with OAG will experience rapid progression over the next two or three years from the time of classification. The performance (AUC) of our model increased by approximately 7% (increased from 0.752 to 0.819) when the Kalman filtering results were incorporated as additional features in the supervised learning model. These results suggest the combination of filters and statistical learning methods in clinical health has significant benefits. Although this paper applies our methodology to OAG, the methodology developed is applicable to other chronic conditions.

Indexed as

GlaucomaGlaucoma, Open-AngleDisease ProgressionHumansPoliticsChronic diseasesClinical decision makingDisease progressionMachine learningPredictive modeling

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.